The near-term trigger for the stock is its plan to acquire Amplitude Surgical. Amplitude had a 5 per cent year-on-year (Y-o-Y ...

Amplitude Surgical is a leading French player in the global market for surgical technologies for lower limb orthopaedics and ...

India still relies largely on imported devices and implants, when it comes to MedTech. This offers us a great opportunity to ...

India's Zydus Lifesciences is set to acquire an 85.6% stake in France's Amplitude Surgical for nearly $280 million to expand ...

Zydus Lifesciences on Tuesday said it has entered into negotiations to acquire a majority stake in France-based Amplitude ...

Zydus Lifesciences announced it is negotiating to acquire a majority stake in French medtech firm Amplitude Surgical for ...

Homegrown pharma company Zydus Lifesciences Ltd announced on Tuesday its strategic move into the medical technology ...

Medical Technology includes medical devices and related scientific infrastructure that directly contribute to the development ...

Zydus is adding growth levers in its medtech segment (cardiology, nephrology, orthopaedics). However, considering stable earnings over FY25-27, we maintain Neutral rating on the stock.

Brokerage firms remain divided on Zydus Lifesciences as the company announced to acquire France-based Amplitude Surgical for ...

Zydus Lifesciences Limited has entered into exclusive negotiations to purchase3 from PAI Partners and Amplitude Surgical's ...

Zydus will focus on state-of-the-art manufacturing capabilities that will enable high quality solutions for patients with cutting-edge research and innovation, reports Financial Express.